Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression. Local targets link to admitted publications; unresolved targets remain external evidence.
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
10.1016/j.cell.2020.02.052 · 2020 · External reference
Structural and functional basis of SARS-CoV-2 entry by using human ACE2
10.1016/j.cell.2020.03.045 · 2020 · External reference
10.1126/science.abb2762
10.1126/science.abb2762 · External reference
10.1038/s41586-020-2180-5
10.1038/s41586-020-2180-5 · External reference
10.1161/01.res.0000205761.22353.5f
10.1161/01.res.0000205761.22353.5f · External reference
10.1186/s40249-020-00662-x
10.1186/s40249-020-00662-x · External reference
Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract
10.1016/j.devcel.2020.05.012 · 2020 · External reference
10.1016/j.ejim.2020.04.037
10.1016/j.ejim.2020.04.037 · External reference
ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19
10.18632/aging.103100 · 2020 · External reference
A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection
10.21037/atm.2020.03.61 · 2020 · External reference
Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis
10.1186/s13045-020-00883-5 · 2020 · External reference
Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients
10.1002/ijc.33145 · 2020 · External reference
ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
10.1186/s13046-019-1156-5 · 2019 · External reference
The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer
2010 · External reference
The ACE2/angiotensin-(1–7)/Mas receptor axis: pleiotropic roles in cancer
10.3389/fphys.2017.00276 · 2017 · External reference
Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro
2011 · External reference
Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer
10.7150/jca.49462 · 2020 · External reference
Bioinformatic analysis of correlation between immune infiltration and COVID-19 in cancer patients
10.7150/ijbs.48639 · 2020 · External reference
10.1158/2326-6066.cir-16-0019
10.1158/2326-6066.cir-16-0019 · External reference
10.1158/1078-0432.ccr-17-0270
10.1158/1078-0432.ccr-17-0270 · External reference
10.1158/2326-6066.cir-16-0072
10.1158/2326-6066.cir-16-0072 · External reference
10.1371/journal.pmed.1002309
10.1371/journal.pmed.1002309 · External reference
GSVA: gene set variation analysis for microarray and RNA-Seq data
10.1186/1471-2105-14-7 · 2013 · External reference
10.1093/nar/gkw1092
10.1093/nar/gkw1092 · External reference
10.1073/pnas.0506580102
10.1073/pnas.0506580102 · External reference
10.1186/1471-2105-9-559
10.1186/1471-2105-9-559 · External reference
Controlling the false discovery rate: a practical and powerful approach to multiple testing
10.1111/j.2517-6161.1995.tb02031.x · 1995 · External reference
10.3389/fimmu.2014.00217
10.3389/fimmu.2014.00217 · External reference
Essential role of interferon regulatory factor 4 (IRF4) in immune cell development
10.1007/s12272-016-0854-1 · 2016 · External reference
10.1016/s0092-8674(00)80702-3
10.1016/s0092-8674(00)80702-3 · External reference
